| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |